Bluejay Diagnostics, Inc.
BJDX
$1.66
-$0.11-6.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 25.54% | 22.46% | 14.43% | 12.10% | 0.82% |
| Total Depreciation and Amortization | -70.85% | -74.50% | -72.54% | -28.60% | 69.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,186.36% | 72.59% | 154.34% | -15.13% | -102.02% |
| Change in Net Operating Assets | -98.05% | -195.52% | -396.47% | -58.01% | 1,123.87% |
| Cash from Operations | 12.65% | 5.90% | -4.50% | 6.50% | 12.70% |
| Capital Expenditure | 31.99% | 56.45% | 53.95% | 70.23% | 73.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 31.99% | 56.45% | 53.95% | 70.23% | 73.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -44,366.67% | -41,585.42% | -51,911.36% | -59,840.63% | -125.00% |
| Issuance of Common Stock | 68.34% | 658.71% | 645.18% | 47,166.09% | 17,515.22% |
| Repurchase of Common Stock | 73.33% | 99.32% | -- | 100.00% | 97.40% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -0.63% | -344.11% | -325.88% | -11,198.50% | -5,531.50% |
| Cash from Financing | 87.83% | 819.84% | 784.91% | 21,601.87% | 7,907.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 111.04% | 126.48% | 108.27% | 128.88% | 60.16% |